| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $3.14 | $2.11 | $1.28 | $1.45 |
| EPS (Diluted) | $2.78 | $1.98 | $1.25 | $1.40 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Total Assets | $4.9B | $4.4B | $3.8B | $2.5B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.3B | $0.3B | $0.3B |
| Total Liabilities | $4.5B | $4.0B | $3.4B | $2.2B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | $0.5B | $0.4B | $0.4B | $0.3B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.0B | $0.0B |
| Investing Cash Flow | $-0.5B | $-0.5B | $-1.2B | $-0.5B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.5B | $0.6B | $1.2B | $0.6B |